Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

1452446

	registered interest
	date	18/03/2022
	answering body	Department for Business, Energy and Industrial Strategy
	answering dept id	201
	answering dept short name	Business, Energy and Industrial Strategy
	answering dept sort name	Business, Energy and Industrial Strategy
	hansard heading	Science: Research
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, what steps his his Department has taken to support scientific research consortia as a future funding model for domestic R&D.
	tabling member constituency	Hendon
	tabling member printed	Dr Matthew Offord
	uin	142443
	answer	answer is ministerial correction date of answer 28/03/2022 answer text <p>Support for research consortia is a well-established aspect of the UK Government’s approach to funding R&amp;D. Between 2015 – 2021, UK Research and Innovation provided over 16,500 research and innovation grants, over 65% of which were collaborative awards.[1] [2]</p><p> </p><p>SR21 sets out the government’s plan to cement the UK as a global science and technology superpower, with public spending on R&amp;D rising to £20bn in 2024/25, an increase of around a quarter in real terms over the SR period.</p><p> </p><p>As the custodian of the R&amp;D system, BEIS has been allocated £39.8bn for R&amp;D over the SR period, the largest ever budget committed to BEIS for R&amp;D. This investment will continue to support both individual researchers and groups of researchers working in consortia to solve the biggest challenges facing society.</p><p> </p><p>It will also encourage private sector investments and give the market players the confidence that they are backing national priorities – so that the public and private sector can come together to deliver breakthroughs, like the Covid-19 vaccine, that can transform our lives and economic prospects.</p><p> </p><p><em>[1] <a href="https://www.ukri.org/publications/competitive-funding-decisions-data-2015-to-2020/" target="_blank">https://www.ukri.org/publications/competitive-funding-decisions-data-2015-to-2020/</a> </em></p><p><em> </em></p><p><em>[2] <a href="https://www.ukri.org/publications/competitive-funding-decisions-data-2020-to-2021" target="_blank">https://www.ukri.org/publications/competitive-funding-decisions-data-2020-to-2021</a></em></p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 28/03/2022 14:09:50 answering member 4020 label Biography information for George Freeman
	tabling member	4006 label Biography information for Dr Matthew Offord

1452447

	registered interest
	date	18/03/2022
	answering body	Department for Business, Energy and Industrial Strategy
	answering dept id	201
	answering dept short name	Business, Energy and Industrial Strategy
	answering dept sort name	Business, Energy and Industrial Strategy
	hansard heading	Research: Finance
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, what assessment has been made of how the model of collaborative funding for covid-19 research at pace can be used to fund other research areas.
	tabling member constituency	Hendon
	tabling member printed	Dr Matthew Offord
	uin	142444
	answer	answer is ministerial correction date of answer 25/03/2022 answer text <p>I refer the Hon. Member to the answer I gave to the Hon. Member for Strangford on 15 February 2022 to Question UIN 119577.</p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 25/03/2022 12:02:38 answering member 4020 label Biography information for George Freeman
	tabling member	4006 label Biography information for Dr Matthew Offord

1452445

	registered interest
	date	18/03/2022
	answering body	Department for Business, Energy and Industrial Strategy
	answering dept id	201
	answering dept short name	Business, Energy and Industrial Strategy
	answering dept sort name	Business, Energy and Industrial Strategy
	hansard heading	Cancer: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, what recent steps his Department has taken to support research into cancer immune therapies.
	tabling member constituency	Hendon
	tabling member printed	Dr Matthew Offord
	uin	142442
	answer	answer is ministerial correction date of answer 25/03/2022 answer text <p>Medical Research Council, as part of UK Research and Innovation (UKRI) funds research relevant to cancer immune therapies as part of its wider cancer portfolio. Development of cancer vaccines and immune therapies, including immune-oncology work into Chimeric antigen receptor (CAR-T) approaches and immunotherapies, is funded through MRC’s research boards, panels and Unit and Institutes.</p><p> </p><p>For example, research into cancer immune therapies have been supported through MRC’s Developmental Pathway Funding Scheme such as research taking place at Great Ormond Street Hospital which is aiming to use novel base editing techniques to develop new CAR-T approaches to treat Leukemia in Children. In addition, research at Queen Mary, University of London is looking at Tumour-targeting oncolytic viruses, a new class of therapeutic that has shown immense promise in clinical trials for a number of different cancers and provide a promising platform for development of curative therapies for pancreatic cancer.</p><p> </p><p>MRC has also supported research through its Units including research at the MRC Clinical Trials Unit which is focusing on new drugs including immune-oncology drugs, and artificial intelligence technologies to improve cancer treatments. There is also research at the MRC Toxicology Unit looking at using new technologies to better understand the immune system and to investigate how and why toxicity develops. This knowledge will help to design interventions that make immune therapies safer and more widely available.</p><p> </p><p>MRC always welcomes high quality applications for support into any aspect of human health and these are judged in open competition with other demands on funding. Awards are made according to their scientific quality and importance to human health.</p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 25/03/2022 11:58:12 answering member 4020 label Biography information for George Freeman
	tabling member	4006 label Biography information for Dr Matthew Offord

1452440

	registered interest
	date	18/03/2022
	answering body	Department for Business, Energy and Industrial Strategy
	answering dept id	201
	answering dept short name	Business, Energy and Industrial Strategy
	answering dept sort name	Business, Energy and Industrial Strategy
	hansard heading	Horizon Europe
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, what progress has been made on the ratification of the UK’s association with the EU’s Horizon Europe programme.
	tabling member constituency	Hendon
	tabling member printed	Dr Matthew Offord
	uin	142440
	answer	answer is ministerial correction date of answer 25/03/2022 answer text <p>The UK stands ready to formalise our association to EU programmes at the earliest opportunity. The UK raised the ongoing delays at the EU-UK Specialised Committee on Participation in Union Programmes in December. In this meeting the EU confirmed that they were unwilling to move on UK association due to broader political issues. The minutes from this meeting can be found on <a href="https://www.gov.uk/government/publications/specialised-committee-on-participation-in-union-programmes-minutes-21-december-2021" target="_blank">gov.uk</a>. We continue to push the EU to formalise our association to Horizon Europe as soon as possible.</p><p> </p><p>We recognise that the EU’s delays to the UK’s association have led to uncertainty for researchers, businesses and innovators based in the UK. In order to provide reassurance, the Government guaranteed funding for the first wave of eligible successful applicants to Horizon Europe. On 15 March, the Government announced an extension of the guarantee to a second wave of eligible, successful applicants to ensure that important international collaborations can continue and to provide reassurance for future collaborations.</p><p> </p><p>This guarantee protects researchers whether we associate to Horizon Europe, or not. The Government’s position remains to associate and we will continue to do everything we can, but the UK cannot wait indefinitely. If the UK is unable to associate to Horizon Europe soon, and in time to make full use of the opportunities it offers, we are committed to introducing a comprehensive alternative programme of international science, research and innovation collaborations. These will focus on both immediate stability for the sector, with short-term mitigations including the guarantee of funding for successful Horizon applicants, and a bold and ambitious longer-term offer that delivers many of the benefits of Horizon association, and additional benefits, through wider global participation, and even stronger industry and SME engagement.</p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 25/03/2022 11:56:49 answering member 4020 label Biography information for George Freeman
	tabling member	4006 label Biography information for Dr Matthew Offord

1452442

	registered interest
	date	18/03/2022
	answering body	Department for Business, Energy and Industrial Strategy
	answering dept id	201
	answering dept short name	Business, Energy and Industrial Strategy
	answering dept sort name	Business, Energy and Industrial Strategy
	hansard heading	Research: Government Assistance
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, what steps his Department has taken to develop the UK R&D Roadmap into the forthcoming R&D Plan.
	tabling member constituency	Hendon
	tabling member printed	Dr Matthew Offord
	uin	142441
	answer	answer is ministerial correction date of answer 25/03/2022 answer text <p>Published in July 2020, the R&amp;D Roadmap set out the Government’s vision and ambition for the next chapter for UK research and development.</p><p>BEIS is focusing on implementation and delivery of the Roadmap and of subsequent strategies, such as the Innovation and People and Culture Strategies. The objectives of the Roadmap are also being driven through the independently led Reviews of Research Bureaucracy and the Research, Development and Innovation Organisational Landscape.</p><p>The Department recently received its largest ever R&amp;D budget at SR21 – £39.8bn over the SR period. We have now set out how funding will be allocated across our partner organisations over the next three years.</p><p>We have also announced the Advanced Research and Invention Agency (ARIA), for which the Government has committed £800 million to by 2025/2026 to fund high-risk high-reward research.</p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 25/03/2022 11:53:41 answering member 4020 label Biography information for George Freeman
	tabling member	4006 label Biography information for Dr Matthew Offord